South Korea
· Delayed Price · Currency is KRW Genesem Statistics
Total Valuation
Genesem has a market cap or net worth of KRW 62.79 billion. The enterprise value is 68.40 billion.
| Market Cap | 62.79B |
| Enterprise Value | 68.40B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Genesem has 8.77 million shares outstanding.
| Current Share Class | 8.77M |
| Shares Outstanding | 8.77M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.36% |
| Owned by Institutions (%) | 0.57% |
| Float | 4.88M |
Valuation Ratios
The trailing PE ratio is 14.67.
| PE Ratio | 14.67 |
| Forward PE | n/a |
| PS Ratio | 0.96 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | 10.66 |
| P/OCF Ratio | 8.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.68, with an EV/FCF ratio of 11.62.
| EV / Earnings | 15.99 |
| EV / Sales | 1.05 |
| EV / EBITDA | 11.68 |
| EV / EBIT | 14.90 |
| EV / FCF | 11.62 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.36 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.44 |
| Debt / FCF | 3.42 |
| Interest Coverage | 5.42 |
Financial Efficiency
Return on equity (ROE) is 9.40% and return on invested capital (ROIC) is 4.34%.
| Return on Equity (ROE) | 9.40% |
| Return on Assets (ROA) | 3.39% |
| Return on Invested Capital (ROIC) | 4.34% |
| Return on Capital Employed (ROCE) | 8.39% |
| Revenue Per Employee | 420.62M |
| Profits Per Employee | 27.61M |
| Employee Count | 155 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, Genesem has paid 642.69 million in taxes.
| Income Tax | 642.69M |
| Effective Tax Rate | 13.06% |
Stock Price Statistics
The stock price has decreased by -35.90% in the last 52 weeks. The beta is 1.42, so Genesem's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -35.90% |
| 50-Day Moving Average | 7,144.20 |
| 200-Day Moving Average | 7,702.45 |
| Relative Strength Index (RSI) | 50.68 |
| Average Volume (20 Days) | 40,047 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesem had revenue of KRW 65.20 billion and earned 4.28 billion in profits. Earnings per share was 487.96.
| Revenue | 65.20B |
| Gross Profit | 26.87B |
| Operating Income | 4.59B |
| Pretax Income | 4.92B |
| Net Income | 4.28B |
| EBITDA | 5.86B |
| EBIT | 4.59B |
| Earnings Per Share (EPS) | 487.96 |
Balance Sheet
The company has 14.38 billion in cash and 20.15 billion in debt, giving a net cash position of -5.77 billion or -658.01 per share.
| Cash & Cash Equivalents | 14.38B |
| Total Debt | 20.15B |
| Net Cash | -5.77B |
| Net Cash Per Share | -658.01 |
| Equity (Book Value) | 47.94B |
| Book Value Per Share | 5,484.79 |
| Working Capital | 11.22B |
Cash Flow
In the last 12 months, operating cash flow was 7.75 billion and capital expenditures -1.86 billion, giving a free cash flow of 5.89 billion.
| Operating Cash Flow | 7.75B |
| Capital Expenditures | -1.86B |
| Free Cash Flow | 5.89B |
| FCF Per Share | 671.49 |
Margins
Gross margin is 41.22%, with operating and profit margins of 7.04% and 6.56%.
| Gross Margin | 41.22% |
| Operating Margin | 7.04% |
| Pretax Margin | 7.55% |
| Profit Margin | 6.56% |
| EBITDA Margin | 8.98% |
| EBIT Margin | 7.04% |
| FCF Margin | 9.03% |
Dividends & Yields
This stock pays an annual dividend of 75.00, which amounts to a dividend yield of 1.04%.
| Dividend Per Share | 75.00 |
| Dividend Yield | 1.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.04% |
| Earnings Yield | 6.82% |
| FCF Yield | 9.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 10, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Nov 10, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Genesem has an Altman Z-Score of 2.71 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 8 |